


Searching News Database: GCS-100
HSMN NewsFeed - 15 Oct 2013
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Additional items found! 9
Members Archive contains
9 additional stories matching:
GCS-100
(Password required)
GCS-100
(Password required)
